| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Dermata Therapeutics Inc. Common Stock (NASDAQ: DRMA)
DRMA Technical Analysis
3
| As on 9th Jun 2023 DRMA STOCK Price closed @ 1.73 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.98 & Buy for SHORT-TERM with Stoploss of 1.65 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DRMASTOCK Price
| Open | 1.87 | Change | Price | % |
| High | 1.90 | 1 Day | -0.18 | -9.42 |
| Low | 1.72 | 1 Week | 0.11 | 6.79 |
| Close | 1.73 | 1 Month | -0.26 | -13.07 |
| Volume | 158300 | 1 Year | -0.60 | -25.75 |
| 52 Week High 3.84 | 52 Week Low 0.18 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| DRMA Daily Charts |
DRMA Intraday Charts |
Whats New @ Bazaartrend |
DRMA Free Analysis |
|
|
DRMA Important Levels Intraday
| RESISTANCE | 2.08 |
| RESISTANCE | 1.97 |
| RESISTANCE | 1.90 |
| RESISTANCE | 1.83 |
| SUPPORT | 1.63 |
| SUPPORT | 1.56 |
| SUPPORT | 1.49 |
| SUPPORT | 1.38 |
DRMA Forecast April 2024
| 4th UP Forecast | 4.64 |
| 3rd UP Forecast | 3.71 |
| 2nd UP Forecast | 3.13 |
| 1st UP Forecast | 2.55 |
| 1st DOWN Forecast | 0.91 |
| 2nd DOWN Forecast | 0.33 |
| 3rd DOWN Forecast | -0.25 |
| 4th DOWN Forecast | -1.18 |
DRMA Weekly Forecast
| 4th UP Forecast | 3.39 |
| 3rd UP Forecast | 2.86 |
| 2nd UP Forecast | 2.53 |
| 1st UP Forecast | 2.20 |
| 1st DOWN Forecast | 1.26 |
| 2nd DOWN Forecast | 0.93 |
| 3rd DOWN Forecast | 0.60 |
| 4th DOWN Forecast | 0.07 |
DRMA Forecast2024
| 4th UP Forecast | 10.67 |
| 3rd UP Forecast | 7.8 |
| 2nd UP Forecast | 6.03 |
| 1st UP Forecast | 4.26 |
| 1st DOWN Forecast | -0.8 |
| 2nd DOWN Forecast | -2.57 |
| 3rd DOWN Forecast | -4.34 |
| 4th DOWN Forecast | -7.21 |
Dermata Therapeutics Inc. Common Stock ( NASDAQ USA Symbol : DRMA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DRMA Business Profile
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, a once-weekly topical product that is under clinical development for the treatment of acne vulgaris, psoriasis vulgaris, and papulopustular rosacea. It is also developing DMT410 for the treatment of hyperhidrosis and aesthetic conditions. The company was founded in 2014 and is headquartered in San Diego, California. Address: 3525 Del Mar Heights Road, San Diego, CA, United States, 92130
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service